Clearside Biomedical Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Bradford T Whitmore | 2 | 580,222 |
George M Lasezkay | 2 | -38,030 |
Nancy J Hutson | 2 | 40,000 |
Clay Thorp | 2 | 24,000 |
Charles A. Deignan | 2 | -26,930 |
Thomas Ciulla | 2 | -15,870 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 7,813 | 0 | 7,813 |
最近3个月 | 137,813 | 0 | 137,813 |
最近6个月 | 582,257 | 30,900 | 551,357 |
最近12个月 | 738,035 | 30,900 | 707,135 |
最近18个月 | 752,035 | 80,830 | 671,205 |
最近36个月 | 782,035 | 80,830 | 701,205 |
Clearside Biomedical Inc 内部交易
Clearside Biomedical Inc 最新内部交易
Benjamin R Yerxa | 董事 | 2024-05-15 | 买入 | 7,813 | 17,957 |
$1.31
|
+2.29%
|
Anthony S Gibney | 董事 | 2024-04-18 | 买入 | 100,000 | 100,000 |
$1.3
|
+3.08%
|
Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | 2024-03-20 | 买入 | 30,000 | 30,000 |
$1.6
|
-16.25%
|
Bradford T Whitmore | 10% Owner | 2024-02-07 | 买入 | 444,444 | 6,845,186 |
$1.35
|
-0.74%
|
George M Lasezkay | CEO | 2024-01-19 | 卖出 | 18,000 | 466,577 |
$1.27
|
+5.51%
|
Charles A. Deignan | CFO | 2024-01-19 | 卖出 | 12,900 | 384,662 |
$1.28
|
+4.69%
|
Bradford T Whitmore | 10% Owner | 2023-11-01 | 买入 | 135,778 | 6,400,742 |
$0.74
|
+81.08%
|
Nancy J Hutson | 董事 | 2023-10-03 | 买入 | 10,000 | 93,000 |
$0.86
|
+55.81%
|
Clay Thorp | 董事 | 2023-09-25 | 买入 | 10,000 | 3,585,562 |
$0.86
|
+55.81%
|
Thomas Ciulla | Chief Medical Officer | 2023-01-20 | 卖出 | 13,700 | 291,890 |
$1.47
|
-8.84%
|